Literature DB >> 1869495

Bright light augmentation in antidepressant nonresponders.

A J Levitt1, R T Joffe, S H Kennedy.   

Abstract

BACKGROUND: This study was designed to examine the potential benefit of the addition of bright lights to antidepressant treatment in depressed subjects.
METHOD: Ten patients who presented during the winter months with major depression and who had failed an adequate trial of antidepressants or who had relapsed following a successful course of antidepressants underwent a 2-week course of bright light therapy.
RESULTS: Augmentation with bright lights resulted in substantial improvement in 7 of the 10 patients.
CONCLUSION: Bright light augmentation may provide a useful treatment alternative for patients with treatment-resistant depression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869495

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  A primary care focus on the treatment of patients with major depressive disorder.

Authors:  Karen Weihs; Jonathan M Wert
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

2.  Side effects of adjunct light therapy in patients with major depression.

Authors:  M J Müller; E Seifritz; M Hatzinger; U Hemmeter; E Holsboer-Trachsler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 3.  Light, melatonin and the sleep-wake cycle.

Authors:  G M Brown
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

4.  The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder.

Authors:  G Papatheodorou; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

5.  Light treatment of mood disorders.

Authors:  Barbara L Parry; Eva L Maurer
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

6.  Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients.

Authors:  Giovanni Camardese; Beniamino Leone; Riccardo Serrani; Coco Walstra; Marco Di Nicola; Giacomo Della Marca; Pietro Bria; Luigi Janiri
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-09       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.